PROJECT OBJECTIVES

NewbioGen Objective

NewBioGen aims to address the currently commercial problems in hip industry by developing an innovative product and a new production process. In more details, NewBioGen project targets to develop new biocompatible raw materials, design and manufacture a scale up production process for the development of orthopaedic hip implants and manufacture of implants with low modulus which will be near to the bone, not toxic, lower price, enhanced wear resistance and will last more than the current solutions currently in the market.

As for the specific Technological and Scientific Objectives, NewBioGen will have four technological objectives and 3 scientific objectives as stated below.

Objectives:

  • Development of biocompatible raw materials mixture with low elastic modulus.
  • Development of orthopaedic implant which will allow the tissue ingrowth through the interconnected pores, the improved tribological and wear resistance properties.
  • Development of an automated mixing and airtight packaging equipment.
  • Development of a ZrO2/Zr coating on the implant with eliminated coating separation risk.
  • Development of an automated scale up production equipment for improved orthopaedic implants.
  • Development of a simulation model for powder metallurgy production process.
  • The next step

    The next step in our novel approach is the application of ZrO2/Zr coating on the implant using Laser Engineered Net Shape techniques to give better wear resistance and lower the possibility of interfacial separation under repeated loading condition.

  • Taking a new route

    NewBioGen is taking a new route to establish methods that yield high precision and quality biomaterials and will validate their increased biocompatibility, wear resistance, corrosion resistance, enhanced mechanical and tribological properties.

  • NewBioGen Project

    NewBioGen Project (Grant Agreement 606112) is supported by the European Commission through the Programme Research for SMEs.

image001       image002 1

 

NewBioGen Project (Grant Agreement 606112) is supported by the European Commission through the Programme Research for SMEs.